A carregar...
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
BACKGROUND: The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy. METHODS: To evaluate the variables that determined the choice of...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3404902/ https://ncbi.nlm.nih.gov/pubmed/22545982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-158 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|